Prometheus Biosciences

Biotech & Life Sciences · San Diego, United States · Founded 1995 · IPO 2021

Committed to the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune disease

Valuation $8.87B

Revenue $6.8M

Power Law Unicorn$1–10B valuation tier

Talent graph

Prometheus Biosciences's talent

Book a demo to see the people

Founders /100 quality score

Key operators quality score

Potential founders likely future founders

Startup mafia 4 alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

10 investors on Prometheus Biosciences's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series B+ 10 investors entered at this stage

Ascend Global Investments

Nestlé

Cowen Group

RTW Investments

Eventide Asset Management

Perceptive Advisors

Cormorant Capital

Cedars-Sinai

Irving Investors

Point72

Prometheus Biosciences mafia

Startups founded by Prometheus Biosciences alumni

Former Prometheus Biosciences employees who went on to start their own companies. Sorted by Dealroom signal score.

Mirador TherapeuticsEst. 2024

MMMark McKennaUnited States

Signal score92

Phathom PharmaceuticalsEst. 2018

David SocksUnited States

Signal score75

SantarusEst. 1996

Scott GlennUnited States

Signal score70

Shoreline BiosciencesEst. 2020

William SandbornUnited States

Signal score61

Book a demo to explore the full alumni network →

Global footprint

Where Prometheus Biosciences has talent and traffic

Workforce by country

🇺🇸 United States · San Diego HQ

Book a demo for the full country breakdown

Patent intelligence

$52M patent portfolio · 57 active families

Estimated portfolio value

$52M

0.59% of market cap · 4.3× smaller than top peer Xencor ($227M)

57 active patent families

Where Prometheus Biosciences innovates Antiendomysial antibodiesAutoimmune inflammatory bowel diseaseBowels diseasesInflammatory bowel diseaseMolecular biology

Where Prometheus Biosciences concentrates vs peers

Each axis is a top-10 topic across Prometheus Biosciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Prometheus Biosciences

An AI-synthesized read of the highest-engagement posts about Prometheus Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Prometheus Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles